COLLEEN LUSTINA: Open Payments
NPI 1346576998 · CROWN POINT, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 87 payments from 20 companies in 2025. Trend: 2023 $1,767 · 2024 $1,719 · 2025 $1,753
Food & beverage: $1,708Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $407 |
| Novo Nordisk Inc | 15 | $320 |
| AstraZeneca Pharmaceuticals LP | 5 | $225 |
| PFIZER INC. | 10 | $171 |
| Phathom Pharmaceuticals, Inc. | 3 | $136 |
| Otsuka America Pharmaceutical, Inc. | 3 | $72 |
| Lilly USA, LLC | 2 | $70 |
| Exact Sciences Corporation | 3 | $55 |
| Tris Pharma Inc | 2 | $40 |
| Amgen Inc. | 2 | $38 |
Products named: UBRELVY, VRAYLAR, VOQUEZNA, Ozempic, NURTEC ODT, Wegovy, BREZTRI, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
